Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza virus vaccine 2004-2005 formulation
- Development stage
- Approved
- Lead developer
- CSL
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The influenza virus vaccine 2004-2005 formulation is a trivalent, inactivated, split-virion vaccine marketed under the brand name Fluzone. It was developed by Sanofi Pasteur (formerly Aventis Pasteur) for the 2004-2005 northern hemisphere influenza season. The vaccine contains hemagglutinin antigens from three specific viral strains: A/New Caledonia/20/99 (H1N1), A/Wyoming/03/2003 (H3N2), and B/Jiangsu/10/2003. Administered via intramuscular injection, it is designed to induce protective antibody responses against these circulating influenza strains in adults and elderly populations.
- Brand names
- Fluzone
- Other names
- trivalent inactivated influenza vaccine2004-2005 flu vaccineinfluenza virus vaccine 2004-2005
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on influenza virus vaccine 2004-2005 formulation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza virus vaccine 2004-2005 formulation.